Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury
Clinical trial NCT04683848 · COMPLETED
Trial details
- NCT number
- NCT04683848
- Sponsor
- Tanabe Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-27
- Primary completion
- 2024-12-24
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.